Khosla and coworkers report the synthesis of peptidic dihydroisoxazole derivatives, the in vitro evaluation of these novel compounds as inhibitors of recombinant human tissue transglutaminase (TG2), and their oral bioavailability and efficacy for the synergistic treatment of glioblastoma tumors [1].
机构:
Univ Roma Tor Vergata, Dept Expt Med, Biochem Lab, IDI IRCCS, I-00133 Rome, ItalyUniv Roma Tor Vergata, Dept Expt Med, Biochem Lab, IDI IRCCS, I-00133 Rome, Italy
De Laurenzi, V
Melino, G
论文数: 0引用数: 0
h-index: 0
机构:
Univ Roma Tor Vergata, Dept Expt Med, Biochem Lab, IDI IRCCS, I-00133 Rome, ItalyUniv Roma Tor Vergata, Dept Expt Med, Biochem Lab, IDI IRCCS, I-00133 Rome, Italy